【title loan in palmdale】3 Reasons Growth Investors Will Love Charles River (CRL)
Growth stocks are attractive to many investors,title loan in palmdale as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.
In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.
However, the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects, makes it pretty easy to find cutting-edge growth stocks.
Charles River Laboratories (CRL) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank.
Research shows that stocks carrying the best growth features consistently beat the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.
While there are numerous reasons why the stock of this medical research equipment and services provider is a great growth pick right now, we have highlighted three of the most important factors below:
Earnings Growth
Earnings growth is arguably the most important factor, as stocks exhibiting exceptionally surging profit levels tend to attract the attention of most investors. And for growth investors, double-digit earnings growth is definitely preferable, and often an indication of strong prospects (and stock price gains) for the company under consideration.
While the historical EPS growth rate for Charles River is 14.5%, investors should actually focus on the projected growth. The company's EPS is expected to grow 13.7% this year, crushing the industry average, which calls for EPS growth of -0.4%.
Cash Flow Growth
Cash is the lifeblood of any business, but higher-than-average cash flow growth is more beneficial and important for growth-oriented companies than for mature companies. That's because, high cash accumulation enables these companies to undertake new projects without raising expensive outside funds.
Right now, year-over-year cash flow growth for Charles River is 16.5%, which is higher than many of its peers. In fact, the rate compares to the industry average of 6.6%.
While investors should actually consider the current cash flow growth, it's worth taking a look at the historical rate too for putting the current reading into proper perspective. The company's annualized cash flow growth rate has been 15.2% over the past 3-5 years versus the industry average of 15%.
Story continues
Promising Earnings Estimate Revisions
Beyond the metrics outlined above, investors should consider the trend in earnings estimate revisions. A positive trend is a plus here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
There have been upward revisions in current-year earnings estimates for Charles River. The Zacks Consensus Estimate for the current year has surged 8.3% over the past month.
Bottom Line
Charles River has not only earned a Growth Score of B based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #2 because of the positive earnings estimate revisions.
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
This combination indicates that Charles River is a potential outperformer and a solid choice for growth investors.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
Charles River Laboratories International, Inc. (CRL) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
View comments
-
Are You Looking for a Top Momentum Pick? Why Vapotherm (VAPO) is a Great ChoiceMT Højgaard Holding A/S: Financial Calendar 2021Machinery Companies' Earnings Due on Nov 5: PH, MIDD & FLSDespite Its High P/E Ratio, Is Ovzon AB (publ) (STO:OVZON) Still Undervalued?Outlook into the Worldwide Plasma Protein Therapeutics to 2025 - Featuring CSL Behring, Biotest AG & Baxter Among OthersBank of Baroda rolls back charges after public outcryKey Things To Consider Before Buying Canaccord Genuity Group Inc. (TSE:CF) For Its DividendDollar Slumps to Multi-year Lows; EUR/USD tracks 1.20FOREX-Dollar on back foot as recovery optimism persistsCoronavirus spread in Canada is slowing - Public Health Agency
下一篇:Plug Power (PLUG) to Report Q4 Earnings: What to Expect?
- ·Sientra to Present at the William Blair 40th Annual Growth Stock Conference
- ·BRIEF-Wangfujing Group, BTG Hotels' Chairman Passed Away Due To Illness
- ·ServiceNow (NOW) Set to Acquire AI-Focused Startup Element AI
- ·PharmaCielo Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In PharmaCielo Ltd. To Contact The Firm
- ·Culp: Q2 Earnings Insights
- ·aTyr Pharma to Webcast Conference Call Reporting Third Quarter 2020 Financial Results - Management to host conference call and webcast on November 12th at 5:00 pm EST / 2:00 pm PST
- ·35 Surprising Cities With Low Costs of Living
- ·A Magnificent Ascent For The Newest Cloud ETF
- ·Petrolympic Announces Closing of Private Placement
- ·Global stocks tumble as US-China tensions escalate
- ·Bioreactors Market Research Report by Material, by Usage, by Scale, by Control Type, by Distrbution - Global Forecast to 2025 - Cumulative Impact of COVID-19
- ·Iran watchdog passes law on hardening nuclear stance, halting UN inspections
- ·Unum (UNM) Q1 Earnings and Revenues Lag Estimates
- ·EUR/USD Price Forecast – Euro Pulls Back And Recognizes Gravity Again
- ·Here's How Long It Took Apple To Reach A $100B Market Cap
- ·Have Insiders Been Buying IKONICS Corporation (NASDAQ:IKNX) Shares?
- ·Global Automotive Plastics Markets, 2020-2027 - Focus on ABS, PP, PU, PVC, PE, PC, PMMA, PA & Others
- ·ICEsoft To Host Investor Call To Present Q3 Financial Results And To Provide A General Business Update
- ·Barr Finds No Election Fraud as DOJ Pursues ‘Bribery for Pardons’ Scheme
- ·Pinduoduo’s AI strawberry competition offers glimpse of “one-click planting”
- ·People are getting this unexpected stimulus check. Should you keep it?
- ·ZoomInfo IPO: What You Need To Know
- ·After Facebook deal, Reliance Jio rakes in $747 million from PE giant Silver Lake
- ·Why Consumer Financial Protection Bureau's structure is a real threat to small business, individual liberty
- ·Why Semtech (SMTC) Stock Might be a Great Pick
- ·10 Block, a Tech Startup Recognized by SXSW 2019, is Releasing a Universal TV Series and Movie Discovery Platform So You Can See What Your Friends Like
- ·Post-Pandemic Retirement Planning Strategy Book Launches on June 1, 2020
- ·Preview: Signet Jewelers's Earnings
- ·NeoPhotonics (NPTN) Misses Q3 Earnings Estimates
- ·Backend Benchmarking Publishes 17th Edition of The Robo Report Covering the 3rd Quarter of 2020
- ·Time To Worry? Analysts Are Downgrading Their Aubay Société Anonyme (EPA:AUB) Outlook
- ·Should Value Investors Buy Avis Budget Group (CAR) Stock?
- ·Dollar Up Despite Vaccine Approval and Possibility of U.S. Stimulus Measures
- ·This Broker Just Slashed Their Freelance.com SA (EPA:ALFRE) Earnings Forecasts
- ·XFC to Live Stream Inaugural Try-Outs in Michigan on Sept 12 Live on Location at Team SFS-Scorpion Fighting System
- ·3 Consumer Cyclical Mutual Funds to Grab in December